{"id":109433,"date":"2025-04-10T11:27:00","date_gmt":"2025-04-10T14:27:00","guid":{"rendered":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/releases\/releases-geral\/bioventra-inc-reports-surge-in-sales-of-flagship-wellness-products-mitolyn-and-primebiome-in-q1-2025\/"},"modified":"2025-04-10T11:27:00","modified_gmt":"2025-04-10T14:27:00","slug":"bioventra-inc-reports-surge-in-sales-of-flagship-wellness-products-mitolyn-and-primebiome-in-q1-2025","status":"publish","type":"post","link":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/releases\/releases-geral\/bioventra-inc-reports-surge-in-sales-of-flagship-wellness-products-mitolyn-and-primebiome-in-q1-2025\/","title":{"rendered":"Bioventra Inc. Reports Surge in Sales of Flagship Wellness Products Mitolyn\u00ae and PrimeBiome\u00ae in Q1 2025"},"content":{"rendered":"

\"BIOVENTRA\"<\/p>\n

JUPITER, Fla., April 10, 2025 (GLOBE NEWSWIRE) — Bioventra Inc., a fast-rising innovator in nutraceutical solutions, today announced record-breaking Q1 sales performance driven by continued consumer demand for two of its flagship wellness supplements: Mitolyn\u00ae and PrimeBiome\u00ae. Both products, part of Bioventras growing line of targeted health formulations, have witnessed exponential interest from global markets due to ongoing shifts in health-conscious consumer behavior.<\/p>\n

According to internal reports, Mitolyn\u00aea mitochondria-support supplement designed to optimize metabolic energyachieved its highest-ever volume of monthly orders in March. Meanwhile, PrimeBiome\u00ae, a gut-skin axis probiotic blend, experienced a 280% spike in new subscriptions compared to January, 2025.<\/p>\n

Were thrilled to see this kind of validation from the market, said a Bioventra<\/u><\/a> spokesperson. We believe consumers are increasingly looking for evidence-driven, responsibly formulated wellness solutionssomething Bioventra has always prioritized. The momentum behind Mitolyn and PrimeBiome reflects both our internal R&D investment and the trust our customers place in us.<\/p>\n

Bioventras strategic product pipeline includes a growing portfolio of bioactive wellness innovations developed in partnership with third-party labs and formulation experts. The companys robust digital infrastructure, including customer education platforms and dedicated partner agencies, has allowed it to meet rising global demand while ensuring a high standard of product integrity.<\/p>\n

Mitolyn\u00ae and PrimeBiome\u00ae are exclusively distributed by authorized agencies 3D Marketing and Services LLC and Stealth Advertising Ltd., which have spearheaded outreach and education initiatives to increase global accessibility via search engines.<\/p>\n

For more information about Bioventra and its product line, visit\u00a0www.bioventra.com<\/u><\/a>.<\/p>\n

A photo accompanying this announcement is available at https:\/\/www.globenewswire.com\/NewsRoom\/AttachmentNg\/621dd111-a32c-4e55-aea7-8ad59264bce9<\/a><\/p>\n

\"\"
\"\"<\/p>\n

SOURCE:\nBioventra Inc.\nMatthew Phoden\ncontact@bioventra.com<\/pre>\n
\n
\n
\n
\n
Bioventra<\/h5>\n<\/div>\n
  <\/a><\/div>\n
\n
\n
Bioventra<\/h5>\n<\/div>\n<\/div>\n<\/div>\n
A OESP<\/b> nao e(sao) responsavel(is) por erros, incorrecoes, atrasos ou quaisquer decisoes tomadas por seus clientes com base nos Conteudos ora disponibilizados, bem como tais Conteudos nao representam a opiniao da OESP<\/b> e sao de inteira responsabilidade da GlobeNewswire<\/b><\/p>\n","protected":false},"excerpt":{"rendered":"JUPITER, Fla., April  10, 2025  (GLOBE NEWSWIRE) — Bioventra Inc., a fast-rising innovator in nutraceutical solutions, today announced record-breakin","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[34],"tags":[],"class_list":["post-109433","post","type-post","status-publish","format-standard","hentry","category-releases-geral"],"acf":[],"_links":{"self":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/posts\/109433","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/comments?post=109433"}],"version-history":[{"count":0,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/posts\/109433\/revisions"}],"wp:attachment":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/media?parent=109433"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/categories?post=109433"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/tags?post=109433"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}